3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Uveal Melanoma
1
Retinal Diseases
1
Melanoma
1
Macular Degeneration
1
Choroid Diseases
1
Interventions
Nivolumab
27
pembrolizumab
22
Ipilimumab
17
Temozolomide
13
toripalimab
12
Biopsy
10
Cyclophosphamide
9
Imiquimod
8
Dacarbazine
7
Blood Specimen Collection
7
camrelizumab
6
Chemotherapy, Adjuvant
6
trametinib
5
fludarabine
5
dabrafenib
5
atezolizumab
5
aldesleukin
5
Gene Expression Profiling
5
Cisplatin
5
Aminolevulinic Acid
5
fludarabine phosphate
4
durvalumab
4
binimetinib
4
apatinib
4
Tomography, Optical Coherence
4
Sorafenib
4
Photochemotherapy
4
Interleukin-2
4
Injections
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
salicylhydroxamic acid
×
Dermatologic
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled